StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Insys Therapeutics (INSY) Provides Upadate on FDA Advisory Committee Meeting Addressing the Co-Prescribing of Naloxone
December 18, 2018 6:12 AM
INSYS Therapeutics, Inc. (NASDAQ: INSY) today announced that Dr. Dean Mariano, senior director, clinical development and medical affairs at INSYS ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA
Management Comments
Next Articles
INSYS Therapeutics Announces Participation at FDA Advisory Committee Meeting Addressing the Co-Prescribing of Naloxone
December 18, 2018 6:00 AM
Insys Therapeutics (INSY) Announces Update on Strategic Alternative Review Process and Product Pipeline
December 17, 2018 6:03 AM